Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChill Brands Regulatory News (CHLL)

Share Price Information for Chill Brands (CHLL)

Share Price is delayed by 15 minutes
Get Live Data
3.25    -0.07 (-2.15%)
Bid:
3.00
Ask:
3.50
Spread: 0.50 (16.667%)
Market Cap: £1.66m
CHLL Live PriceLast checked at - London Stock Exchange

Intraday Chill Brands Share Chart

Agreement for CBD Distribution Support

18 Aug 2022 07:00

RNS Number : 3877W
Chill Brands Group PLC
18 August 2022
Β 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

18 August 2022

Chill Brands Group plc

("Chill Brands" or the "Company")

Β 

CBD Distribution Support

Chill Brands Group, the international consumer packaged goods company, is pleased to announce that it has entered into a brokerage agreement with Bellator Group LLC ("Bellator") to support and expand US distribution of its product lines.

Β 

As part of the agreement, Bellator will work closely with Chill Brands' internal sales team to monitor market trends. This will enable the Company to gather more accurate data and swiftly adapt its sales plans to improve the uptake of Chill products by retail buyers and consumers. In addition to developing and acting on these commercial insights across a significant proportion of the Company's existing distribution channels, Bellator will also market Chill's CBD range and potential future product extensions to its wider network of retail contacts.

Β 

Shane Nance, Co-Founder of Bellator Group, said: "We are excited to work with Chill Brands to help support their existing distribution channels and develop new ones. We have been extremely impressed with their quality product line-up and the Chill brand itself which, with the right vision and execution, has the potential to truly stand out in the retail environment."

Β 

Callum Sommerton, Chief Executive Officer of Chill Brands, commented: "We are thrilled to be working with Bellator Group to refine our approach to retail sales. This relationship forms part of our strategy to work more closely with retailers, ensuring that our products are given the best possible chance to perform. As an established specialist broker for the CBD industry, Bellator has an extensive network of connections and the expertise required to generate success in our primary product category."

Β 

-ENDS-

About Bellator Group

Bellator Group is a specialist CBD product distribution and brokerage firm with a strong track record for supporting and promoting some of the category's most successful and well-known brands.

Bellator selects the industry's best cannabinoid goods and other products, building custom sales programs and providing shopper marketing, education, and direct store delivery distribution to maximise the potential of its chosen brand partners.

Read more at: www.bellatorgroupcbd.com

About Chill Brands Group

Chill Brands Group plc (LSE: CHLL, OTCQB: CHBRF) is an international company concerned with the development, production, and distribution of best-in-class hemp-derived CBD products, tobacco alternatives and other consumer packaged goods (CPG) products. The Company operates primarily in the US, where its products are distributed online and via some of the nation's most recognisable convenience retail outlets. The Group's strategy is anchored around lifestyle marketing that is designed to enhance the popularity of its products, channelling visitors to its landmark chill.com website.

Publication on website

A copy of this announcement is also available on the Group's website at:

http://www.chillbrandsgroup.com

Media enquiries:

Chill Brands Group plc

contact@chillbrandsgroup.com

Allenby Capital Limited (Financial Adviser and Broker)

+44 (0) 20 3328 5656

Nick Harriss/Nick Naylor (Corporate Finance)Kelly Gardiner (Equity Sales)

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
AGREAKPXFLKAEFA
Date   Source Headline
29th May 20264:41 pmRNSShare Capital Reorganisation, PDMR & TVR
19th May 20267:00 amRNSUpdated Timetable for Share Capital Reorganisation
13th May 20263:27 pmRNSResult of AGM
13th May 20267:00 amRNSCommercial Update Ahead of AGM
23rd Apr 20267:00 amRNSCommercial Update
20th Apr 20262:00 pmRNSNotice of AGMs & Share Capital Reorganisation
31st Mar 20267:00 amRNSDirectorate change
9th Feb 20267:00 amRNSTrading Update
25th Nov 20257:00 amRNSChange of Auditor
31st Oct 20255:00 pmRNSTotal Voting Rights
23rd Oct 20257:00 amRNSChill Agrees Settlement with Former Advisers
20th Oct 20257:00 amRNSBusiness and strategy update
1st Oct 20255:21 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSIssue of Equity
19th Sep 20251:30 pmRNSREPLACEMENT-Chill Brands appointed UK Distributor
10th Sep 20257:00 amRNSChill appointed Distributor - ELF Nicotine Pouches
8th Sep 20257:00 amRNSStrategic partnership with SYP Global
5th Sep 202511:00 amRNSHolding(s) in Company
1st Sep 20257:00 amRNSChill Appointed UK Distribution Partner by RELX
22nd Aug 202512:30 pmRNSHolding(s) in Company
11th Aug 20257:45 amRNSCompany Update and Lifting of Suspension
11th Aug 20257:30 amRNSRestoration - Chill Brands Group plc
31st Jul 202512:30 pmRNSInterim Results for the 12 months to 31 March 2025
28th Jul 20257:00 amRNSChange of Accounting Reference Date
11th Jul 20251:00 pmRNSHalf-year Report for the 6 months to 30 Sep 2024
23rd Jun 20257:00 amRNSAnnual Financial Report to 31 March 2024
30th May 20257:00 amRNSUpdate on the publication of financial results
23rd May 20257:00 amRNS£1m raised from issuance of convertible loan notes
24th Apr 20257:00 amRNSFundraising to raise £1m & Update on results
26th Mar 202512:00 pmRNSStatus of audit and publication of accounts
11th Mar 20257:00 amRNSUpdate on Current Business & Proposed Fundraising
19th Dec 20247:00 amRNSCorporate update
9th Dec 20247:00 amRNSCompany Update
30th Sep 20244:30 pmRNSResult of AGM
30th Sep 20247:00 amRNSAGM Statement & Trading Update
5th Sep 20247:00 amRNSDirectorate Change & Notice of AGM
25th Jul 20244:20 pmRNSCommencement of Legal Action
17th Jul 20247:00 amRNSCompany Update & Directorate Changes
10th Jun 20247:00 amRNSDirectorate Change & Company Update
4th Jun 20241:10 pmRNSResult of GM and Board Changes
3rd Jun 20247:53 amRNSSuspension of Trading in Shares
7th May 20245:31 pmRNSPosting of General Meeting Documents
7th May 20242:04 pmRNSNotice of GM
22nd Apr 20247:00 amRNSSuspension of CEO
17th Apr 20243:18 pmRNSReceipt of Requisition Letter
16th Apr 20247:00 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSInvestor Presentation via Investor Meet Company
31st Jan 20245:00 pmRNSTotal Voting Rights
29th Jan 20247:00 amRNSResponse to Government Proposals
26th Jan 20247:00 amRNSEquity Fundraising

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.